Introduction
Herpes labialis: the disease and its treatment 67 topical therapies are probably preferred by patients, they are generally less effective than oral therapies, although two trials have clearly demonstrated that only penciclovir cream has a statistically significant effect on the course of herpes labialis recurrences in immunocompromised patients. Oral famciclovir is recommended for patients desiring a greater treatment effect. The relative efficacy of some of the available treatments are reviewed in the following article.
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Incontrast to the other common herpesvirus infections, herpes labialis infection is sometimes considered to be less severe and debilitating, and may be regarded more as acondition rather than a disease. However, it can have a significant impact on patients. Herpes labialis arises from reactivation of latent herpes simplex virus type 1 (HSV-1) and in a significant number ofpeople it may be sufficiendysevere or frequent to lead them to seek medical treatment. Herpes labialis can significandy interfere in the patient's life. It has been estimated that approximately 10-20% of patients may need treatment, and many more would take an effective treatment if made available to them.
Herpes labialis is a rapidly progressing disease which 'resolves On its own. This means that interventions need to be initiated as early as possible if they are to have an impact on the course of disease. Thus, either the patient must initiate treatment at the first signs of disease or prophylactictherapy must be started, either continuously orduring periods of high risk.
Various topical and oral chemotherapies are now available for the treatment of herpes labialis. Whereas
